8.32 -0.14 (-1.65%) | 07-18 16:00 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 10.26 | 1-year : | 11.48 |
Resists | First : | 8.79 | Second : | 9.82 |
Pivot price | 7.88 ![]() |
|||
Supports | First : | 7.11 | Second : | 5.91 |
MAs | MA(5) : | 7.84 ![]() |
MA(20) : | 7.91 ![]() |
MA(100) : | 7.38 ![]() |
MA(250) : | 8.84 ![]() |
|
MACD | MACD : | 0 ![]() |
Signal : | -0.1 ![]() |
%K %D | K(14,3) : | 32.1 ![]() |
D(3) : | 21.5 ![]() |
RSI | RSI(14): 55.3 ![]() |
|||
52-week | High : | 13.88 | Low : | 4.8 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CYBN ] has closed below upper band by 26.6%. Bollinger Bands are 11.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 8.51 - 8.56 | 8.56 - 8.6 |
Low: | 8.05 - 8.1 | 8.1 - 8.15 |
Close: | 8.24 - 8.33 | 8.33 - 8.41 |
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
Fri, 18 Jul 2025
Wall Street Analysts See an 831.44% Upside in Cybin Inc. (CYBN): Can the Stock Really Move This High? - Yahoo Finance
Thu, 17 Jul 2025
Three High-Risk, High-Reward Stocks in AI, Biotech, and Autonomous Vehicles - AInvest
Thu, 17 Jul 2025
Major Breakthrough: Cybin's Depression Drug Enters Global Phase 3 Trial After UK Green Light - Stock Titan
Wed, 16 Jul 2025
Three High-Risk, High-Reward Stocks with Explosive Upside: Rezolve AI, Aurora Innovation, and Cybin Inc. - AInvest
Fri, 11 Jul 2025
Cybin: Upgrade To Hold - But Don't Get Too Carried Away (NYSE:CYBN) - Seeking Alpha
Mon, 30 Jun 2025
Cybin Inc. Advances Mental Health Innovations with Strategic Partnerships and Clinical Progress - TipRanks
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
AMEX
|
|
Sector:
Healthcare
|
|
Industry:
Biotechnology
|
|
Shares Out | 760 (M) |
Shares Float | 574 (M) |
Held by Insiders | 6.9 (%) |
Held by Institutions | 38.3 (%) |
Shares Short | 14,900 (K) |
Shares Short P.Month | 12,740 (K) |
EPS | -0.16 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0.37 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -32.8 % |
Return on Equity (ttm) | -49.1 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.12 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -85 (M) |
Levered Free Cash Flow | -50 (M) |
PE Ratio | -55.47 |
PEG Ratio | 0 |
Price to Book value | 22.48 |
Price to Sales | 0 |
Price to Cash Flow | -74 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |